Public data, as of October 2026

Company profile

Takeda Pharmaceutical Company Limited

TAKtakeda.comLatest disclosure 2023

Takeda Pharmaceutical Company Limited reported about 4.3 million tCO₂e for 2023, and 93% of it sits in Scope 3, in the value chain beyond the company's own operations.

Is this your company? Claim it

SBTi statusValidated Targets

Near-term status: Validated Targets. Net-zero status: Validated Targets.

Where insetting fits

Scope 3 is 93% of the footprint, the part of the value chain that supplier emissions reductions can reach.

Peer position

Scope 3 is 93% of the footprint, close to the peer median of 91%.

Voluntary retirements

No voluntary retirement names this company as beneficiary yet.

Emissions

How the reported footprint breaks down by scope and year.

tCO₂e, GHG Protocol scopes
Source: published disclosure, FY2023

Peer benchmark

How Takeda Pharmaceutical Company Limited compares with its industry peers on Scope 3.

Peers: companies in the SBTi industry "Pharmaceuticals, Biotechnology and Life Sciences", by Scope 3 share of the latest reported footprint.

CompanyScope 3 share%

Takeda Pharmaceutical Company LimitedThis company93%
McKesson Corporation99%

Company profile

A claimed profile keeps the figures accurate and shows the company’s projects.

Claiming is free. Your team can correct data, add newer disclosures and list reduction projects from your value chain, so that customers and suppliers can co-fund them.

Claim this profile Talk to Carbon3

1
Confirm employment at the company

Related projects

None yet

Inset projects on Carbon3None yet

Reported emissions by year

Scope 1
Scope 2
Scope 3

FY2023

Scope 1, direct	279,0007%
Scope 2, purchased energy	33,0001%
Scope 3, value chain	3,953,00093%
Total	4,265,000

Years without a matched disclosure stay open until a published source is matched.

Source document: assets-dam.takeda.com

Scope 3 by category, 2023

10 categories itemized

C1Purchased Goods and ServicesLargest category2.7 Mt68%
C2Capital Goods241 kt6%
C3Fuel and Energy Related Activities147 kt4%
C4Upstream Transportation and Distribution353 kt9%
C5Waste Generated in Operations17 kt<1%
C6Business Travel117 kt3%
C7Employee Commuting67 kt2%
C10Processing of Sold Products1 kt<1%
C12End-of-Life Treatment of Sold Products264 kt7%
C15Investments57 kt1%

Climate targets

What the SBTi listing says about the company's targets.

Status as published by the SBTi

Primary SBTi record: Takeda Pharmaceutical Company

Near-term targetValidated Targets

Classification: 1.5°C
Target year: 2030

Net-zero targetValidated Targets

Net-zero year: 2040

Carbon3 shows each record exactly as the SBTi publishes it, and does not assess, rate or endorse targets. A validated target says nothing about any market instrument.

Voluntary retirements

Voluntary credits retired for this company on public registries.

Registry records naming the company as beneficiary

No voluntary credit retirements linked to this company

Carbon3 has not found a retirement in the public voluntary carbon market registry data it tracks that names this company as the beneficiary.

Bayer Aktiengesellschaft74%

Thermo Fisher Scientific Inc.94%

Merck & Co., Inc.87%

AstraZeneca plc98%

Merck KGaA81%

Peer median: 91%Scope 3 boundaries differ between reports, so compare shares with care.

Scope 3 position

Near the peer median

The company's Scope 3 share is 93%, against a peer median of 91%.

Disclosure coverage

6 of 6 disclose

6 of 6 named peers report all three scopes, so their Scope 3 share can be compared.

Research summary

What the public record says about this company's decarbonization.

No report has been generated for this company yet

Anyone can read a cached company report, while generating a new one can take a few minutes and needs a free account.

Related projects

Decarbonization projects that name the company as a partner.

Emerging projects catalog, status as reported by each project

No projects linked to this company yet

Carbon3 has not yet found a public decarbonization project that names this company.

No inset projects are listed for this company yet.

Suppliers to Takeda Pharmaceutical Company Limited can list a reduction project on Carbon3 at no cost, so that the company could co-fund it.

List a supplier project

Sign in with an email address at the company's own domain.

2

Review the data

Flag corrections and upload newer disclosures, which Carbon3 checks against a published source.

3

List a project at no cost

Turn verified supply-chain reductions into inset credits that partners can co-fund.

A free account also gives access to downloads, alerts and new research reports.